Ireland· IE-PA-EU/1/22/1625/001
Paxlovid 150 mg + 100 mg Film-coated tablet
A nirmatrelvir und ritonavir product containing pf-07321332, registered in Ireland by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Nirmatrelvir und ritonavir is registered in 11 of 19 countries.
Countries holding a registration under ATC J05AE30 (nirmatrelvir und ritonavir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Nirmatrelvir und ritonavir · ATC J05AE30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of nirmatrelvir und ritonavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nirmatrelvir und ritonavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$851.25
The record
At a glance
HPRA (Ireland)- Active substance
- PF-07321332
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Ireland (IE)
- ATC code
- J05AE30
- ATC class
- Nirmatrelvir und Ritonavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1625/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for nirmatrelvir und ritonavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nirmatrelvir und ritonavir · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Nirmatrelvir und ritonavir in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97d9d98e-5dae-4c29-b356-825c3c85ab14 GET /v1/drugs/97d9d98e-5dae-4c29-b356-825c3c85ab14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AE30"
],
"strength": null,
"pa_number": "EU/1/22/1625/001",
"substances": [
"PF-07321332"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "27/01/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about nirmatrelvir und ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.